As our findings are limited to the middle temporal cortex, further studies quantifying IGF2R circRNA in additional cortical regions, such as the parietal cortex are necessary to evaluate its use as a biomarker for AD and to fully understand the mechanisms of hsa_circ_0131235 in AD pathogenesis. The gene discussed is IGF2R; the disease is Alzheimer disease.